| Quang Thanh Nguyen, MD | |
|
3305 Sw 34th Cir, Suite 200, Ocala, FL 34474-6616 | |
| (352) 401-7575 | |
| (352) 401-7577 |
| Full Name | Quang Thanh Nguyen |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 17 Years |
| Location | 3305 Sw 34th Cir, Ocala, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922209675 | NPI | - | NPPES |
| 003752401 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | ME109477 (Florida) | Secondary |
| 207R00000X | Internal Medicine | ME109477 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pinnacle Home Care Of The Villages Inc | Fruitland park, FL | Home health agency |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Simedhealth Llc | 6608137054 | 82 |
News Archive
University of Alabama at Birmingham researcher X. Long Zheng, M.D., Ph.D., has received a five-year, $2.5 million National Institutes of Health grant to study the pathogenesis of thrombotic microangiopathy, or TMA. In simple terms, this means looking for factors that cause or aid the onset of extensive microscopic clots in small blood vessels throughout the body. Though tiny, these spots can damage kidneys, heart and brain, and they can cause death.
A Queen's University study has found that when people think about having children, men want boys and women want girls.
Celator Pharmaceuticals today announced that new data from a preclinical leukemia study in mice demonstrate that its lead product, CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, alone or in combination with clofarabine or azacytidine can improve treatment outcomes compared to the combination of either agent with the conventional (unencapsulated) cytarabine:daunorubicin regimen.
Rosetta Genomics, Ltd has announced that it has partnered with NYU Medical Center with the aim of developing a line of early detection diagnostic products for lung, and Mesothelioma cancers.
› Verified 5 days ago
| Entity Name | Southeastern Integrated Medical Pl |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871573949 PECOS PAC ID: 4981697216 Enrollment ID: O20040405000448 |
News Archive
University of Alabama at Birmingham researcher X. Long Zheng, M.D., Ph.D., has received a five-year, $2.5 million National Institutes of Health grant to study the pathogenesis of thrombotic microangiopathy, or TMA. In simple terms, this means looking for factors that cause or aid the onset of extensive microscopic clots in small blood vessels throughout the body. Though tiny, these spots can damage kidneys, heart and brain, and they can cause death.
A Queen's University study has found that when people think about having children, men want boys and women want girls.
Celator Pharmaceuticals today announced that new data from a preclinical leukemia study in mice demonstrate that its lead product, CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, alone or in combination with clofarabine or azacytidine can improve treatment outcomes compared to the combination of either agent with the conventional (unencapsulated) cytarabine:daunorubicin regimen.
Rosetta Genomics, Ltd has announced that it has partnered with NYU Medical Center with the aim of developing a line of early detection diagnostic products for lung, and Mesothelioma cancers.
› Verified 5 days ago
| Entity Name | Simedhealth Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639680127 PECOS PAC ID: 6608137054 Enrollment ID: O20180227000525 |
News Archive
University of Alabama at Birmingham researcher X. Long Zheng, M.D., Ph.D., has received a five-year, $2.5 million National Institutes of Health grant to study the pathogenesis of thrombotic microangiopathy, or TMA. In simple terms, this means looking for factors that cause or aid the onset of extensive microscopic clots in small blood vessels throughout the body. Though tiny, these spots can damage kidneys, heart and brain, and they can cause death.
A Queen's University study has found that when people think about having children, men want boys and women want girls.
Celator Pharmaceuticals today announced that new data from a preclinical leukemia study in mice demonstrate that its lead product, CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, alone or in combination with clofarabine or azacytidine can improve treatment outcomes compared to the combination of either agent with the conventional (unencapsulated) cytarabine:daunorubicin regimen.
Rosetta Genomics, Ltd has announced that it has partnered with NYU Medical Center with the aim of developing a line of early detection diagnostic products for lung, and Mesothelioma cancers.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Quang Thanh Nguyen, MD 4881 Nw 8th Ave, Suite, Gainesville, FL 32605-4582 Ph: (352) 373-6338 | Quang Thanh Nguyen, MD 3305 Sw 34th Cir, Suite 200, Ocala, FL 34474-6616 Ph: (352) 401-7575 |
News Archive
University of Alabama at Birmingham researcher X. Long Zheng, M.D., Ph.D., has received a five-year, $2.5 million National Institutes of Health grant to study the pathogenesis of thrombotic microangiopathy, or TMA. In simple terms, this means looking for factors that cause or aid the onset of extensive microscopic clots in small blood vessels throughout the body. Though tiny, these spots can damage kidneys, heart and brain, and they can cause death.
A Queen's University study has found that when people think about having children, men want boys and women want girls.
Celator Pharmaceuticals today announced that new data from a preclinical leukemia study in mice demonstrate that its lead product, CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, alone or in combination with clofarabine or azacytidine can improve treatment outcomes compared to the combination of either agent with the conventional (unencapsulated) cytarabine:daunorubicin regimen.
Rosetta Genomics, Ltd has announced that it has partnered with NYU Medical Center with the aim of developing a line of early detection diagnostic products for lung, and Mesothelioma cancers.
› Verified 5 days ago
Joana Vicente Vargas, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3304 Se Lake Weir Ave, Ste 3, Ocala, FL 34471 Phone: 352-620-9181 Fax: 352-620-9193 | |
Dr. Sanjay A Patel, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 419 Sw 15th St Ste 100, Ocala, FL 34471 Phone: 352-732-6400 Fax: 352-671-5283 | |
Dr. Kevin Jay Colver, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Sw 1st Ave, Ocala, FL 34471 Phone: 352-671-2254 Fax: 352-671-2291 | |
Bhavani Ketheeswaran, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2810 Se 3rd Ct, Ocala, FL 34471 Phone: 352-732-0122 | |
Juan C Bustillo, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 3301 Sw 34th Cir Ste 101, Ocala, FL 34474 Phone: 352-861-0100 Fax: 352-861-1119 | |
Dr. Lon Helton Mcpherson, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 716 Se 36th Ln, Ocala, FL 34471 Phone: 352-553-5499 | |
Dr. Karthikram Komanduri, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1431 Sw 1st Ave, Ocala, FL 34471 Phone: 352-401-8312 |